相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of Fluconazole, Amphotericin B, and Caspofungin on Candida albicans Biofilms under Conditions of Flow and on Biofilm Dispersion
Priya Uppuluri et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Efficacy of anidulafungin against biofilms of different Candida species in long-term trials of continuous flow cultivation
Hannelore Bernhardt et al.
MYCOSES (2011)
Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex
Analy S. Melo et al.
MEDICAL MYCOLOGY (2011)
In Vivo Efficacy of Anidulafungin against Mature Candida albicans Biofilms in a Novel Rat Model of Catheter-Associated Candidiasis
Sona Kucharikova et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Pathogenesis of invasive candidiasis
Frank L. van de Veerdonk et al.
CURRENT OPINION IN CRITICAL CARE (2010)
In vitro activity of antifungal combinations against Candida albicans biofilms
Selma Tobudic et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases
Selma Tobudic et al.
MYCOSES (2010)
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2009)
Design of a Simple Model of Candida albicans Biofilms Formed under Conditions of Flow: Development, Architecture, and Drug Resistance
Priya Uppuluri et al.
MYCOPATHOLOGIA (2009)
Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms
Aspasia Katragkou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Changing pattern of candidaemia 2001-2006 and use of antifungal therapy at the University Hospital of Vienna, Austria
E. Presterl et al.
CLINICAL MICROBIOLOGY AND INFECTION (2007)
Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species
Analy S. Melo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Candida albicans biofilms produce antifungal-tolerant persister cells
Michael D. LaFleur et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model
Jennifer A. Shuford et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Biofilm matrix of Candida albicans and Candida tropicalis:: chemical composition and role in drug resistance
Mohammed A. Al-Fattani et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Bloodstream infections due to Candida species in the intensive care unit:: Identifying especially high-risk patients to determine prevention strategies
RP Wenzel et al.
CLINICAL INFECTIOUS DISEASES (2005)
Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole:: a longitudinal study
H Lamfon et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Persister cells and tolerance to antimicrobials
I Keren et al.
FEMS MICROBIOLOGY LETTERS (2004)
Development and characterization of an in vivo central venous catheter Candida albicans biofilm model
D Andes et al.
INFECTION AND IMMUNITY (2004)
Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli
I Keren et al.
JOURNAL OF BACTERIOLOGY (2004)
Rabbit model of Candida albicans biofilm infection:: Liposomal amphotericin B antifungal lock therapy
MK Schinabeck et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Antifungal combinations against Candida albicans biofilms in vitro
SP Bachmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Mechanism of fluconazole resistance in Candida albicans biofilms:: Phase-specific role of efflux pumps and membrane sterols
PK Mukherjee et al.
INFECTION AND IMMUNITY (2003)
Uses and limitations of the XTT assay in studies of Candida growth and metabolism
DM Kuhn et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Antifungal susceptibility of Candida biofilms:: Unique efficacy of amphotericin B lipid formulations and echinocandins
DM Kuhn et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Biofilms: Survival mechanisms of clinically relevant microorganisms
RM Donlan et al.
CLINICAL MICROBIOLOGY REVIEWS (2002)
Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans
I Bekersky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms
G Ramage et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Biofilm formation by the fungal pathogen Candida albicans:: Development, architecture, and drug resistance
J Chandra et al.
JOURNAL OF BACTERIOLOGY (2001)
Mechanisms of biofilm resistance to antimicrobial agents
TFC Mah et al.
TRENDS IN MICROBIOLOGY (2001)
Current and future antifungal therapy: new targets for antifungal therapy
VT Andriole
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2000)
Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents
GS Baillie et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
分享论文
